1 Hyperkolesterolemiaa ilmoitettiin jopa 5, 3%: lla potilaista, joita hoidettiin rosiglitatsonilla (monoterapia, kaksois - tai kolmoishoito). ###>1 Hypercholesterolaemia was reported in up to 5.3% of patients treated with rosiglitazone (monotherapy, dual or triple oral therapy).